000			01854 a2200529 4500
005			20250516194030.0
264		0	_c20140929
008			201409s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0086795 _2doi
040			_aNLM _beng _cNLM
100	1		_aSzalowska, Ewa
245	0	0	_aModel steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. _h[electronic resource]
260			_bPloS one _c2014
300			_ae86795 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmiodarone _xpharmacology
650	0	4	_aAnimals
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aExtracellular Matrix _xdrug effects
650	0	4	_aFatty Liver _xchemically induced
650	0	4	_aGene Expression _xdrug effects
650	0	4	_aGene Expression Profiling
650	0	4	_aHepatocytes _xdrug effects
650	0	4	_aHumans
650	0	4	_aLipid Metabolism _xdrug effects
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aModels, Biological
650	0	4	_aOligonucleotide Array Sequence Analysis
650	0	4	_aPPAR alpha _xagonists
650	0	4	_aPPAR gamma _xagonists
650	0	4	_aPPAR-beta _xagonists
650	0	4	_aTetracycline _xpharmacology
650	0	4	_aTissue Culture Techniques
650	0	4	_aTranscriptome
650	0	4	_aValproic Acid _xpharmacology
700	1		_avan der Burg, Bart
700	1		_aMan, Hai-Yen
700	1		_aHendriksen, Peter J M
700	1		_aPeijnenburg, Ad A C M
773	0		_tPloS one _gvol. 9 _gno. 1 _gp. e86795
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0086795 _zAvailable from publisher's website
999			_c23509828 _d23509828